Form D · Other
KisoTerra Biotech Corp.
Vancouver, A1 · CIK 0001754473
Offering snapshot reported Feb 5, 2025 · SEC filing
- Reported sold
- $24.2K Offering amount: $24.2K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2025 | Initial | $24,165 | No comparison | 1 | SEC filing |
| Jan 22, 2025 | Initial | $250,000 | No comparison | 3 | SEC filing |
| May 30, 2024 | Initial | $10,000 | No comparison | 1 | SEC filing |
| Jul 7, 2021 | Initial | $3,725,000 | No comparison | Not reported | SEC filing |
| Nov 2, 2020 | Initial | $210,000 | No comparison | 2 | SEC filing |
| Mar 27, 2019 | Initial | $20,000 | No comparison | 1 | SEC filing |
| Nov 15, 2018 | Initial | $13,734 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537476
Total Offering Amount represents price of 100,000 common shares sold at CAD$0.35 converted to USD.
Common Shares.
Source: Form D, filed Feb 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Branda | Director, Executive |
| Douglas Frankiw | Director |
| Rich Frontain | Director |
| Daniel Hunter | Director, Executive |
| Brent Hunter | Executive |
| John Johnston | Director, Executive |
| Dirk Lange | Executive |
| Lawrence Lund | Director, Executive |
| Kenneth Philippe | Executive |
| Josef Reschreiter | Director, Executive |
| Michael Stocker | Director |
| David Work | Director |
| Dave Work | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1090 Homer Street Suite 300
Vancouver, A1, V6B 2W9
Vancouver, A1, V6B 2W9